People · Operator
Named in public records as an officer, director or promoter · active 2014–2023 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avicena, LLC | — | Other | Series A | $58.1M | $54.1M | 2014 |
| Foldax, Inc. | — | Other | Series A | $38.7M | $39.4M | 2014 |
| Nexstim Plc | — | Biotechnology | Seed | $3.7M | $166.4M | 2014 |
Ken Charhut at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ken Charhut on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Morteza Gharib | 2 | 5 |
| Mory Gharib | 2 | 3 |
| Brant Heise | 1 | 10 |
| George Wallace | 1 | 8 |
| Scott Huennekens | 1 | 7 |
| Casper Breum | 1 | 5 |
| James Demetriades | 1 | 4 |
| Sean Brady | 1 | 4 |
| Kenneth Charhut | 1 | 4 |
| Greg Casciaro | 1 | 4 |
| Johan Christenson | 1 | 3 |
| Renee Masi | 1 | 3 |
| Matthew Tasooji | 1 | 2 |
| Keith Dawkins | 1 | 2 |
| Rene Kuijten | 1 | 2 |
| Juha Vapaavuori | 1 | 1 |
| Janne Huhtala | 1 | 1 |
| Rainer Harjunpaa | 1 | 1 |
| Frank Maguire | 1 | 1 |
| Demetriades James | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.